Prostate cancer in omics era

Karczewski KJ, Snyder MP. Integrative omics for health and disease. Nat Rev Genet. 2018;19(5):299–310.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Suravajhala P, Kogelman LJ, Kadarmideen HN. Multi-omic data integration and analysis using systems genomics approaches: methods and applications in animal production, health and welfare. Genet Sel Evol. 2016;48(1):1–14.

Article  CAS  Google Scholar 

Karahalil B. Overview of systems biology and omics technologies. Curr Med Chem. 2016;23(37):4221–30.

CAS  PubMed  Article  Google Scholar 

Vucic EA, Thu KL, Robison K, Rybaczyk LA, Chari R, Alvarez CE, et al. Translating cancer ‘omics’ to improved outcomes. Genome Res. 2012;22(2):188–95.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69(1):7–34.

PubMed  Article  Google Scholar 

Wang G, Zhao D, Spring DJ, DePinho RA. Genetics and biology of prostate cancer. Genes Dev. 2018;32(17–18):1105–40.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Parry M, Cowling T, Sujenthiran A, Nossiter J, Berry B, Cathcart P, et al. Risk stratification for prostate cancer management: value of the Cambridge Prognostic Group classification for assessing treatment allocation. BMC Med. 2020;18(1):1–9.

Article  Google Scholar 

Eggener SE, Cifu AS, Nabhan C. Prostate cancer screening. JAMA. 2015;314(8):825–6.

CAS  PubMed  Article  Google Scholar 

Thompson IM, Pauler DK, Goodman PJ, Tangen CM, Lucia MS, Parnes HL, et al. Prevalence of prostate cancer among men with a prostate-specific antigen level ≤4.0 ng per milliliter. N Engl J Med. 2004;350(22):2239–46.

CAS  PubMed  Article  Google Scholar 

Merriel SW, Pocock L, Gilbert E, Creavin S, Walter FM, Spencer A, et al. Systematic review and meta-analysis of the diagnostic accuracy of prostate-specific antigen (PSA) for the detection of prostate cancer in symptomatic patients. BMC Med. 2022;20(1):1–11.

Article  CAS  Google Scholar 

Heidenreich A, Pfister D, Merseburger A, Bartsch G. Castration-resistant prostate cancer: where we stand in 2013 and what urologists should know. Eur Urol. 2013;64(2):260–5.

PubMed  Article  Google Scholar 

Taşan M, Musso G, Hao T, Vidal M, MacRae CA, Roth FP. Selecting causal genes from genome-wide association studies via functionally coherent subnetworks. Nat Methods. 2015;12(2):154–9.

PubMed  Article  CAS  Google Scholar 

Weischenfeldt J, Simon R, Feuerbach L, Schlangen K, Weichenhan D, Minner S, et al. Integrative genomic analyses reveal an androgen-driven somatic alteration landscape in early-onset prostate cancer. Cancer Cell. 2013;23(2):159–70.

CAS  PubMed  Article  Google Scholar 

Grasso CS, Wu Y-M, Robinson DR, Cao X, Dhanasekaran SM, Khan AP, et al. The mutational landscape of lethal castration-resistant prostate cancer. Nature. 2012;487(7406):239–43.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Dupont WD, Breyer JP, Johnson SH, Plummer WD, Smith JR. Prostate cancer risk variants of the HOXB genetic locus. Sci Rep. 2021;11(1):11385.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Caspari R, Friedl W, Mandl M, Möslein G, Kadmon M, Knapp M, et al. Familial adenomatous polyposis: mutation at codon 1309 and early onset of colon cancer. Lancet (London, England). 1994;343(8898):629–32.

CAS  Article  Google Scholar 

McKinley JM, Weideman PC, Jenkins MA, Friedlander ML, Hopper JL, McLachlan S-A, et al. Prostate screening uptake in Australian BRCA1 and BRCA2 carriers. Hered Cancer Clin Pract. 2007;5(3):161.

PubMed  PubMed Central  Article  Google Scholar 

Mur P, García-Mulero S, Del Valle J, Magraner-Pardo L, Vidal A, Pineda M, et al. Role of POLE and POLD1 in familial cancer. Genet Med. 2020;22(12):2089–100.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Zhuang Y, Wang H, Jiang D, Li Y, Feng L, Tian C, et al. Multi gene mutation signatures in colorectal cancer patients: predict for the diagnosis, pathological classification, staging and prognosis. BMC Cancer. 2021;21(1):380.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Robinson D, Van Allen EM, Wu Y-M, Schultz N, Lonigro RJ, Mosquera J-M, et al. Integrative clinical genomics of advanced prostate cancer. Cell. 2015;161(5):1215–28.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Seifert M, Peitzsch C, Gorodetska I, Börner C, Klink B, Dubrovska A. Network-based analysis of prostate cancer cell lines reveals novel marker gene candidates associated with radioresistance and patient relapse. PLoS Comput Biol. 2019;15(11): e1007460.

PubMed  PubMed Central  Article  CAS  Google Scholar 

Tomlins SA, Bjartell A, Chinnaiyan AM, Jenster G, Nam RK, Rubin MA, et al. ETS gene fusions in prostate cancer: from discovery to daily clinical practice. Eur Urol. 2009;56(2):275–86.

CAS  PubMed  Article  Google Scholar 

Klezovitch O, Risk M, Coleman I, Lucas JM, Null M, True LD, et al. A causal role for ERG in neoplastic transformation of prostate epithelium. Proc Natl Acad Sci. 2008;105(6):2105–10.

PubMed  PubMed Central  Article  Google Scholar 

Henzler C, Li Y, Yang R, McBride T, Ho Y, Sprenger C, et al. Truncation and constitutive activation of the androgen receptor by diverse genomic rearrangements in prostate cancer. Nat Commun. 2016;7(1):1–12.

Article  CAS  Google Scholar 

Chen M, Zhang J, Sampieri K, Clohessy JG, Mendez L, Gonzalez-Billalabeitia E, et al. An aberrant SREBP-dependent lipogenic program promotes metastatic prostate cancer. Nat Genet. 2018;50(2):206–18.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Tomlins SA, Laxman B, Varambally S, Cao X, Yu J, Helgeson BE, et al. Role of the TMPRSS2-ERG gene fusion in prostate cancer. Neoplasia (New York, NY). 2008;10(2):177–88.

CAS  Article  Google Scholar 

Tan H-L, Sood A, Rahimi HA, Wang W, Gupta N, Hicks J, et al. Rb loss is characteristic of prostatic small cell neuroendocrine carcinoma. Clin Cancer Res. 2014;20(4):890–903.

CAS  PubMed  Article  Google Scholar 

Pritchard CC, Offit K, Nelson PS. DNA-repair gene mutations in metastatic prostate cancer. N Engl J Med. 2016;375(18):1804–5.

PubMed  Google Scholar 

Shenoy D, Packianathan S, Chen AM, Vijayakumar S. Do African-American men need separate prostate cancer screening guidelines? BMC Urol. 2016;16(1):1–6.

Article  Google Scholar 

Li J, Xu C, Lee HJ, Ren S, Zi X, Zhang Z, et al. A genomic and epigenomic atlas of prostate cancer in Asian populations. Nature. 2020;580(7801):93–9.

CAS  PubMed  Article  Google Scholar 

Brouwer I, Lenstra TL. Visualizing transcription: key to understanding gene expression dynamics. Curr Opin Chem Biol. 2019;51:122–9.

CAS  PubMed  Article  Google Scholar 

Pope SD, Medzhitov R. Emerging principles of gene expression programs and their regulation. Mol Cell. 2018;71(3):389–97.

CAS  PubMed  Article  Google Scholar 

Marzec J, Ross-Adams H, Pirrò S, Wang J, Zhu Y, Mao X, et al. The transcriptomic landscape of prostate cancer development and progression: an integrative analysis. Cancers. 2021;13(2):345.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Alkhateeb A, Rezaeian I, Singireddy S, Cavallo-Medved D, Porter LA, Rueda L. Transcriptomics signature from next-generation sequencing data reveals new transcriptomic biomarkers related to prostate cancer. Cancer Inf. 2019;18:1176935119835522.

Google Scholar 

Solé C, Goicoechea I, Goñi A, Schramm M, Armesto M, Arestin M, et al. The urinary transcriptome as a source of biomarkers for prostate cancer. Cancers (Basel). 2020;12(2):513.

PubMed Central  Article  CAS  Google Scholar 

Fabbri M, Girnita L, Varani G, Calin GA. Decrypting noncoding RNA interactions, structures, and functional networks. Genome Res. 2019;29(9):1377–88.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Eke I, Bylicky MA, Sandfort V, Chopra S, Martello S, Graves EE, et al. The lncRNAs LINC00261 and LINC00665 are upregulated in long-term prostate cancer adaptation after radiotherapy. Mol Ther-Nucleic Acids. 2021;24:175–87.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Tang Y, Pan J, Huang S, Peng X, Zou X, Luo Y, et al. Downregulation of miR-133a-3p promotes prostate cancer bone metastasis via activating PI3K/AKT signaling. J Exp Clin Cancer Res. 2018;37(1):1–16.

Article  CAS  Google Scholar 

留言 (0)

沒有登入
gif